Filing Details
- Accession Number:
- 0001796271-20-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-11 17:28:00
- Reporting Period:
- 2020-08-07
- Accepted Time:
- 2020-08-11 17:28:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1656472 | Cronos Group Inc. | CRON | Medicinal Chemicals & Botanical Products (2833) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1796271 | Kevin Todd Abraham | 111 Peter Street, Suite 300 Toronto A6 M5V 2G9 | Chief Innovation Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2020-08-07 | 15,000 | $5.78 | 15,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.79, inclusive. The reporting person undertakes to provide to Cronos Group Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
